Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication

Blood

Volumn 103, Issue 12, 2004, Pages 4440-4448

  Gammaitoni, Loretta ^b   Weisel, Katja C ^b   Gunetti, Monica ^b   Wu, Kai Da ^b   Bruno, Stefania ^b   Pinelli, Silvana ^b   Bonati, Antonio ^b   Aglietta, Massimo ^b   Moore, Malcolm A S ^b   Piacibello, Wanda ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD34 ANTIGEN; CYTOKINE; TELOMERASE; THROMBOPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIVISION; CELL FUNCTION; CELL POPULATION; COLONY FORMING UNIT; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; STEM CELL; STEM CELL MOBILIZATION; STROMA; STROMA CELL; TELOMERE; TELOMERE LENGTH; TELOMERE LOSS; UMBILICAL CORD BLOOD;

EID: 2942620004     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-09-3079     Document Type: Article

References (32)

1. Moore MAS. In vitro and in vivo hematopoiesis. In: Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM, eds. Atlas of Blood Cells: Function and Pathology. 3rd ed. Milan, Italy: Arti Grafiche Salea; 2003:1-38.
2. Kondo M, Wagers AJ, Manz MG, et al. Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol. 2003;21:759-806.
3. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol. 2002;41:29-40.
4. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells. Blood. 1997;90:182-193.
5. Engelhardt M, MacKenzie K, Drullinsky P, Silver RT, Moore MAS. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Cancer Res. 2000;60:610-617.
6. Vazir H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci U S A. 1994.91:9857-9860.
7. Moore MAS. Commentary: Umbilical cord blood: an expendable resource. J Clin Invest. 2000;105:855-856.
8. Rubinstein P, Carrier C, Carpenter C, et al. Graft selection in unrelated placental/umbilical cord blood (PCB) transplantation: influence and weight of HLA match and cell dose on engraftment and survival [abstract]. Blood. 2000;96:588a.
9. Laughlin MJ, Barker J, Bambach B, et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med. 2001;344:1815-1822.
10. Grewal SS, Barker JN, Davies SM, Wagner JE. Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood? Blood. 2003;101:4233-4244.
11. Jaroscak J, Goltry K, Smith A, et al. Augmentation of umbilical cord blood (Ucb) transplantation With ex-vivo expanded UCB cells: results of a phase I trial using the Aastrom Replicell system. Blood. 2003;101:5061-5067.
12. Piacibello W, Sanavio F, Garetto L, et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood. 1997;89:2644-2653.
13. Piacibello W, Sanavio F, Garetto L, et al. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia. 1998;12:718-727.
14. Piacibello W, Sanavio F, Severino A, et al. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 1999;93:3736-3749.
15. - progenitor cells in long-term cultures and semisolid assays. Blood. 1993;81:2916-2924.
16. Breems DA, Blokland EAW, Neben S, Ploemacher RE. Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia. 1994;8:1095-1104.
17. Moore KA, Ema H, Lemischka IR. In vitro maintenance of highly purified, transplantable hematopoietic stem cells, Blood. 1997;89:4337-4347.
18. + cell co-cultures with murine osteopetrotic stromal cells, OP9, transfected with adenovirus expressing thrombopoietin [abstract]. Blood. 2000;96:666a.
19. + cells on human endothelium transfected with adenovectors expressing thrombopoietin, C-kit ligand and Flk-2 ligand. J Hematother Stem Cell Res. 2002;11:127-138.
20. Glimm H, Eaves CJ. Direct evidence for multiple self-renewal divisions of human in vivo repopulating hematopoietic cells in short-term culture. Blood. 1999;94:2161-2168.
21. Ueda T, Tsuji K, Yoshino H, et al. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000;105:1013-1021.
22. Gammaitoni L, Bruno S, Sanavio F, et al. Ex vivo expansion of human adult stem cells capable of primary and secondary hemopoietic reconstitution. Exp Hematol. 2003;31:261-270.
23. Jo D-Y, Rafii S, Hamada T, Moore MAS. Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. J Clin Invest. 2000;105:101-111.
24. Rufer N, Dragowska W, Thombury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol. 1998;16:743-747.
25. Wu K, Orme L, Shaughnessy J, Jacobson JJ, Barlogie B, Moore MAS. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status and overall survival. Blood. 2003;101:4982-4989.
26. Kodama H, Nose M, Niida S, Yamasaki A. Essential role of macrophage colony-stimulating factor in the osteoclast differentiation supported by stromal cells. J Exp Med. 1991;73:1291-1294.
27. MacKenzie KL, Franco S, May C, Sadelain M, Moore MAS. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp Cell Res. 2000;259:336-350.
28. Franco S, MacKenzie KL, Dias S, Alvarez S, Rafii S, Moore MAS. Clonal variation in phenotype and lifespan of human embryonic fibroblasts (MRC-5) transduced with the catalytic component of telomerase (hTERT), Exp Cell Res. 2001,268:14-25.
29. Liu K, Hodes RJ, Weng N. Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol. 2001;166:4826-4830.
30. Rufer N, Brummendorf TH, Chapuis B, Helg C, Lansdorp PM, Roosnek E. Accelerated telomere shortening in hematological lineages is limited to the first year following stem cell transplantation. Blood. 2001;98:888-890.
31. Zhu, J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci U S A. 1999;96:3723-3728.
32. Cawthorn RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393-395.